Skip to main content

Find Clinical Trials

Home
Conditions
Bronchial Neoplasms

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,259 public trials 1,188 recruiting studies

Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Not Yet Recruiting

SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）

NCT07633873

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer

NCT07637513

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited Stage Small-Cell Lung Cancer, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer Trial 2

NCT07146230

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Not Yet Recruiting

QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer

NCT07636226

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Single-Center Intelligent Pulmonary Rehabilitation After Lung Cancer Surgery

NCT07631533

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer

NCT07322341

Conditions: Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Not Yet Recruiting

Universal Immunization to Fortify Immunotherapy Efficacy and Response

NCT07597070

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Nebulized AER101 in Pre-op NSCLC

NCT07631299

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: OU Medical Center Hospital Oklahoma City, Oklahoma, United States

Stephenson Cancer Center Oklahoma City, Oklahoma, United States

View Trial Details

Not Yet Recruiting

Pharmacokinetic Study of Pembrolizumab and Its Impact on Immunity and the Tumor Microenvironment, Which May Explain the Efficacy of Post-immunotherapy Chemotherapy.

NCT07633613

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

NCT07623642

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details